Investment Q&A

Q: Am thinking of selling JNJ due to ongoing legal issues and replacing with either CVS or RTN. I have other health care exposure with ABT and BMY but nothing in defence sector. Thoughts?

Q: Hi Peter & Ryan, I’m very light in the healthcare sector after recently selling JNJ. I rely on dividends to supplement my pension income and was looking at DR:CA, EXE:CA and SIA:CA. Can you please comment on each of these, quality of the companies, management, safety of the dividend etc. Feel free to suggest other names not listed Canadian or US. Dividend payers preferred. ( I already hold csh.un and used to own sis). Thanks. Mario

Q: Hi Everyone at 5i! JNJ has been in the news quite a bit lately with the newest issue being a law suit for billions of dollars launched by the state of Oklahoma for JNJ’s role in the opioid crisis.
I hold a tidy number of stocks in this company , which I have held for years and I am up quite a bit on the stock. My objective is a long term hold....so my question....how serious is this law suit to the overall value of the company? Should the share value fall, would this be an opportunity to buy more? Or....should I take the money and run ? Looking for some crystal ball insight....Cheers, Tamara

Q: With the recent problems JNJ is facing regarding opioids, would a switch to NVS {novartis] make sense? Held in a US$ RRIF.
Thanks

Q: Good afternoon,

What is your opinion on the long term trajectory on owning JNJ should the outcome in the Oklahoma opiod prescription trial find for the state? Is this a material concern?

Thank you,

Q: I am very fortunate to be a member of 5I,Thanks
I wish you were actively advising on US stocks meanwhile however
for me to start please suggest some US stocks or etf for not very aggressive
stocks with high volatility but something like BNS,SLF,td in Canada Income is not my priority but steady growth is in my mind not stocks like canabis?
I appreciate your sugestion and has always benefited from them
Nizar

Q: In response to a question about a subscriber's portfolio you said “KO and JNJ we would consider less attractive for various reasons. We might add VZ and PFE instead.”. I am holding JNJ in a non-registered account with a cost base of $58.36/share. JNJ is 2.5% of a diversified portfolio. Is it still worth making the switch for PFE? Over the years, JNJ seemed to be a much better managed company than PFE. What has changed?

Q: Hi 5i, please comment on my international div. group for global income or your own top 5 picks, thanks.

Q: I am looking for a replacement for JNJ, recently sold. US$ to be held in a taxable account. Current healthcare holdings are Savaria, Knight, and Stryker.
2-3 suggestions would be appreciated.
Thank you

Q: Good morning,

Two questions this morning. Both are would you make the switch?

I have JNJ that I bought at the $65.00 range back in 2011I think. Would you sell and switch it to ABBV?? Or stay the course?

Same goes for PPL. I have owned it for quite a while and it has gone up nice. Would you switch it to IPL or stay the course?

Thanks
Jimmy

Q: I have a position of about 4% in JNJ, which is still showing a return on investment of 52% even after last week's plunge. It's in a regular account so is liable for tax. In view of the current litigation concerns, would you recommend that I hang tight and see if it comes back, sell the lot and get out while I am ahead, or hedge and sell half. I am what most people would consider to be elderly - I don't have twenty years to wait for a recovery.
B.

Q: Who knows, with the recent news on Costco and JNJ which one would be better going forward today for the short-term?

Q: What are your thoughts about buying any of the above stocks? Thank you, rose

Q: Hi 5i,

I own all the above in the healthcare sector. After reading many comments on JNJ, I am getting a bit concerned. Would you continue to hold on or would you replace it with something else in the same sector? It is inside an RSP so no tax for selling and it is a long term hold as I do t need the money for over a decade.

TIA!

Q: I only own 2 USA stocks, JNJ and PFE. JNJ has grown over the years to 2 full positions so I need to reduce my holdings in JNJ. JNJ pays a nice 2.7% dividend and has grown significantly. What recommendations would you have for a replacement that pays a similar dividend and has some growth potential. I am retired and rely upon the dividends generated in my RRIF.

Wayne

Q: Recently, 5i has supported members' suggestions to switch out of JNJ into something else given the legal difficulties that JNJ faces. I generally like to hold indefinitely; given this anticipated time frame, and my preference for safety and a good/growing dividend, do you think I should switch as well? Do you view the alternatives I've listed as less or more risky than JNJ overall? Are there non-pharmaceutical alternatives in the US healthcare space that would provide an equally secure and growing dividend that you would recommend? Thank you.

Q: Johnson and Johnson is a highly rated company. However they are facing a large number of law suits, mostly related to talcum powder. Although the scientific basis for these lawsuits is extremely weak, I am concerned about the legal system in the USA. Would you recommend I keep holding my JNJ shares or sell and invest in something else in the USA? Diversification is not an issue.

Q: Healthcare is approximately 10% of our portfolio. Medical Facilities is the largest investment which we have held for a long time. JNJ and HCP we have added more recently. NVS and AZN we inherited. We want to simplify our portfolio and plan to sell NVS and AZN and add to JNJ. Wonder what your opinion is of DR and HCP specifically and also AZN which I didn't see mentioned in your question section.
Thank you, Marie

Q: Hello, I am looking to add IHI to the healthcare allocation of my portfolio (10%) but would like to sell one existing holding first. Current healthcare related holdings are JNJ, ABBV, GUD and SIS (although I have SIS filed under Industrials). My question: which of JNJ and ABBV would you advise selling? Thank-you.

Q: We have a 3.5% weighting in JNJ. We like it for its exposure to the USD, its steady dividend income, its blue-chip size and very modest share price growth. However I am concerned about the potential losses arising from their "baby-powder" lawsuit. We have owned the stock for years. I am thinking about switching out around 2% weighting into PFE. Its dividend appears to be higher and its chart seems to be better.
Reading over 5i responses on JNJ you seem fairly sanguine about JNJ so I hesitate to sell. We are retired but not currently spending our USD dividends - they are kept for foreign travel.
I must say I like XBI's chart. However its dividend is much lower so potentially we would need to sell stock if we needed USD. XBI should lower our risk profile as it is an ETF which is probably a smart move.
My questions are...
1) Would you recommend selling all our part of our JNJ or just do nothing?
2) Would you recommend purchasing PFE or XBI or both?
Please deduct as many credits as you feel my question(s) justify.
Thank you for your assistance.
Jim